交易 Cullinan Therapeutics Inc - CGEM
Cullinan Therapeutics Inc (NASDAQ: CGEM) is a clinical-stage oncology company advancing a diversified pipeline of targeted therapies and biologics. Its modular development model focuses on precision immuno-oncology with multiple assets in Phase 1/2 trials. Cullinan presents high-upside optionality from multiple shots on goal in cancer treatment innovation.最新股票文章

SpaceX上市首日收涨19%——IPO后如何交易SpaceX SPCX差价合约
SpaceX(SPCX)于2026年6月12日在纳斯达克首次上市,开盘报150美元,收盘报160.95美元,较135美元的IPO发行价上涨19.2%。
08:41, 16 六月 2026


